Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype
- PMID: 30633778
- PMCID: PMC6329503
- DOI: 10.1371/journal.pone.0210353
Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype
Erratum in
-
Correction: Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype.PLoS One. 2024 Nov 19;19(11):e0314310. doi: 10.1371/journal.pone.0314310. eCollection 2024. PLoS One. 2024. PMID: 39561169 Free PMC article.
Abstract
Seasonal influenza is a cause of hospitalization, especially in people with underlying disease or extreme age, and its severity may differ depending on the types and subtypes of circulating viruses. We investigated the factors associated with ICU admission or death in hospitalized patients with severe laboratory-confirmed influenza according to the viral type and subtype. An observational epidemiological study was carried out in patients aged ≥18 years from 12 Catalan hospitals between 2010 and 2016. For each reported case we collected demographic, virological and clinical characteristics. A mixed-effects logistic regression model was used to estimate crude and adjusted ORs. 1726 hospitalized patients were included: 595 (34.5%) were admitted to the ICU and 224 (13.0%) died. Lower ICU admission was associated with age ≥75 years in all influenza types and subtypes and with age 65-74 years for type A. In contrast, the 65-74 and ≥75 years age groups were associated with an increased risk of death in all types and subtypes, especially for type B (aOR 27.42, 95% CI: 4.95-151.93 and 15.96; 95% CI: 3.01-84.68). The comorbidity most closely associated with severe outcomes was immune deficiency, which was associated with death for type B (aOR 9.02, 95% CI: 3.05-26.69) and subtype A(H1N1)pdm09 (aOR 3.16, 95% CI: 1.77-5.66). Older age was a differential factor for ICU admission and death: it was associated with lower ICU admission but a risk factor for death. The comorbidity with the closest association with death was immune deficiency, mainly in influenza type B patients.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.J Infect Dis. 2013 Oct 15;208(8):1305-14. doi: 10.1093/infdis/jit316. Epub 2013 Jul 17. J Infect Dis. 2013. PMID: 23863950
-
Illness Severity in Hospitalized Influenza Patients by Virus Type and Subtype, Spain, 2010-2017.Emerg Infect Dis. 2020 Feb;26(2):220-228. doi: 10.3201/eid2602.181732. Emerg Infect Dis. 2020. PMID: 31961295 Free PMC article.
-
Association between type-specific influenza circulation and incidence of severe laboratory-confirmed cases; which subtype is the most virulent?Clin Microbiol Infect. 2020 Jul;26(7):922-927. doi: 10.1016/j.cmi.2019.11.018. Epub 2019 Nov 22. Clin Microbiol Infect. 2020. PMID: 31760112
-
Demographic, clinical, and virological characteristics of patients with a laboratory-confirmed diagnosis of influenza during three consecutive seasons, 2015/2016-2017/18, in the Islamic Republic of Iran.J Clin Virol. 2020 Mar;124:104281. doi: 10.1016/j.jcv.2020.104281. Epub 2020 Jan 16. J Clin Virol. 2020. PMID: 32007843
-
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study.Lancet Microbe. 2023 Nov;4(11):e903-e912. doi: 10.1016/S2666-5247(23)00187-8. Epub 2023 Sep 25. Lancet Microbe. 2023. PMID: 37769676 Free PMC article.
Cited by
-
Cost-Effectiveness Analysis of Influenza A (H1N1) Chemoprophylaxis in Brazil.Front Pharmacol. 2019 Sep 10;10:945. doi: 10.3389/fphar.2019.00945. eCollection 2019. Front Pharmacol. 2019. PMID: 31572172 Free PMC article.
-
A systematic review and meta-analysis of host genetic factors associated with influenza severity.BMC Genomics. 2021 Dec 20;22(1):912. doi: 10.1186/s12864-021-08240-7. BMC Genomics. 2021. PMID: 34930124 Free PMC article.
-
Trends in Influenza Vaccination Rates in Participants With Airflow Limitation: The Korea National Health and Nutrition Examination Survey 2007-2018.Front Med (Lausanne). 2022 May 3;9:870617. doi: 10.3389/fmed.2022.870617. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35592859 Free PMC article.
-
Comprehensive Medication Management as a Standard of Practice for Managing Uncontrolled Blood Pressure.Front Med (Lausanne). 2021 Aug 3;8:693171. doi: 10.3389/fmed.2021.693171. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34414204 Free PMC article. No abstract available.
-
Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study.Antimicrob Resist Infect Control. 2023 Mar 31;12(1):25. doi: 10.1186/s13756-023-01234-y. Antimicrob Resist Infect Control. 2023. PMID: 37004057 Free PMC article.
References
-
- Treanor JJ. Influenza (including avian influenza and swine influenza) In: Bennett JE, Dolin R, Blaser MJ, editors. Principles and Practice of Infectious Diseases, 8th ed. Philadelphia: Elsevier; 2015. pp. 2000–2024.
-
- WHO. Influenza (Seasonal). 31 Jan 2018. Available from: http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) Cited 7 September 2018.
-
- Wright PF, Neuman G, Kawaoka Y. Othomyxoviruses In: Knipe DM, Howley PM, editors. Fields Virology, 6th ed Philadelphia: Wolters Kluwer; 2013. pp.1186–1243.
-
- Breese JS, Fry AM, Sambhara S, Cox NJ. Inactivated influenza vaccines In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin’s Vaccines, 7th ed Philadelphia: Elsevier, 2018. pp. 456–488.